Locally advanced rectal cancer: management challenges

RF Kokelaar, MD Evans, M Davies, DA Harris, J Beynon Department of Colorectal Surgery, Singleton Hospital, Swansea, UK Abstract: Between 5% and 10% of patients with rectal cancer present with locally advanced rectal cancer (LARC), and 10% of rectal cancers recur after surgery, of which half are li...

Full description

Bibliographic Details
Main Authors: Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J
Format: Article
Language:English
Published: Dove Medical Press 2016-10-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/locally-advanced-rectal-cancer-management-challenges-peer-reviewed-article-OTT
id doaj-067e28e139aa4f3cb689e7bc8b5bb8fe
record_format Article
spelling doaj-067e28e139aa4f3cb689e7bc8b5bb8fe2020-11-24T22:49:55ZengDove Medical PressOncoTargets and Therapy1178-69302016-10-01Volume 96265627229415Locally advanced rectal cancer: management challengesKokelaar RFEvans MDDavies MHarris DABeynon JRF Kokelaar, MD Evans, M Davies, DA Harris, J Beynon Department of Colorectal Surgery, Singleton Hospital, Swansea, UK Abstract: Between 5% and 10% of patients with rectal cancer present with locally advanced rectal cancer (LARC), and 10% of rectal cancers recur after surgery, of which half are limited to locoregional disease only (locally recurrent rectal cancer). Exenterative surgery offers the best long-term outcomes for patients with LARC and locally recurrent rectal cancer so long as a complete (R0) resection is achieved. Accurate preoperative multimodal staging is crucial in assessing the potential operability of advanced rectal tumors, and resectability may be enhanced with neoadjuvant therapies. Unfortunately, surgical options are limited when the tumor involves the lateral pelvic sidewall or high sacrum due to the technical challenges of achieving histological clearance, and must be balanced against the high morbidity associated with resection of the bony pelvis and significant lymphovascular structures. This group of patients is usually treated palliatively and subsequently survival is poor, which has led surgeons to seek innovative new solutions, as well as revisit previously discarded radical approaches. A small number of centers are pioneering new techniques for resection of beyond-total mesorectal excision tumors, including en bloc resections of the sciatic notch and composite resections of the first two sacral vertebrae. Despite limited experience, these new techniques offer the potential for radical treatment of previously inoperable tumors. This narrative review sets out the challenges facing the management of LARCs and discusses evolving management options. Keywords: rectal cancer, exenteration, pelvic sidewall, sacrectomyhttps://www.dovepress.com/locally-advanced-rectal-cancer-management-challenges-peer-reviewed-article-OTTRectal CancerExenterationPelvic SidewallSacrectomy
collection DOAJ
language English
format Article
sources DOAJ
author Kokelaar RF
Evans MD
Davies M
Harris DA
Beynon J
spellingShingle Kokelaar RF
Evans MD
Davies M
Harris DA
Beynon J
Locally advanced rectal cancer: management challenges
OncoTargets and Therapy
Rectal Cancer
Exenteration
Pelvic Sidewall
Sacrectomy
author_facet Kokelaar RF
Evans MD
Davies M
Harris DA
Beynon J
author_sort Kokelaar RF
title Locally advanced rectal cancer: management challenges
title_short Locally advanced rectal cancer: management challenges
title_full Locally advanced rectal cancer: management challenges
title_fullStr Locally advanced rectal cancer: management challenges
title_full_unstemmed Locally advanced rectal cancer: management challenges
title_sort locally advanced rectal cancer: management challenges
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2016-10-01
description RF Kokelaar, MD Evans, M Davies, DA Harris, J Beynon Department of Colorectal Surgery, Singleton Hospital, Swansea, UK Abstract: Between 5% and 10% of patients with rectal cancer present with locally advanced rectal cancer (LARC), and 10% of rectal cancers recur after surgery, of which half are limited to locoregional disease only (locally recurrent rectal cancer). Exenterative surgery offers the best long-term outcomes for patients with LARC and locally recurrent rectal cancer so long as a complete (R0) resection is achieved. Accurate preoperative multimodal staging is crucial in assessing the potential operability of advanced rectal tumors, and resectability may be enhanced with neoadjuvant therapies. Unfortunately, surgical options are limited when the tumor involves the lateral pelvic sidewall or high sacrum due to the technical challenges of achieving histological clearance, and must be balanced against the high morbidity associated with resection of the bony pelvis and significant lymphovascular structures. This group of patients is usually treated palliatively and subsequently survival is poor, which has led surgeons to seek innovative new solutions, as well as revisit previously discarded radical approaches. A small number of centers are pioneering new techniques for resection of beyond-total mesorectal excision tumors, including en bloc resections of the sciatic notch and composite resections of the first two sacral vertebrae. Despite limited experience, these new techniques offer the potential for radical treatment of previously inoperable tumors. This narrative review sets out the challenges facing the management of LARCs and discusses evolving management options. Keywords: rectal cancer, exenteration, pelvic sidewall, sacrectomy
topic Rectal Cancer
Exenteration
Pelvic Sidewall
Sacrectomy
url https://www.dovepress.com/locally-advanced-rectal-cancer-management-challenges-peer-reviewed-article-OTT
work_keys_str_mv AT kokelaarrf locallyadvancedrectalcancermanagementchallenges
AT evansmd locallyadvancedrectalcancermanagementchallenges
AT daviesm locallyadvancedrectalcancermanagementchallenges
AT harrisda locallyadvancedrectalcancermanagementchallenges
AT beynonj locallyadvancedrectalcancermanagementchallenges
_version_ 1725674370922184704